The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology (ACR) Convergence 2025 meeting in ...
There are multiple chapters near you. Select your preferred chapter.
A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes.
Systemic lupus is the most common form of lupus—it’s what most people mean when they refer to “lupus.” Systemic lupus can be mild or severe. Cutaneous lupus erythematosus This form of lupus is limited ...
Medicare Part D provides prescription drug coverage for more than 50 million of America's seniors and those living with chronic diseases like lupus. Part D allows timely, affordable access to ...
Register. Sign-up yourself or your team today. Fundraise. We provide you with all the tools you need to fundraise for lupus research, support and education services all while earning awesome ...
In this Lupus & You recording, medical experts and guest speakers discuss how lupus can affect sexual health, intimacy, and connection, including the impact of menopause. Hear candid conversations, ...
Use your power! Find your walk and register your team today. Fundraise We provide you with all the tools you need to fundraise for lupus research, support and education services all while earning ...
The 34th Annual Lupus Loop and Walk to End Lupus Now is part of the Lupus Foundation of America’s signature walk program. Hosted by the Pennsylvania Delaware Valley Region of the Lupus Foundation of ...
This isn’t just another conference, it’s a celebration of strength, community, and progress. We’re bringing together patients, families, doctors, researchers, and advocates who all share one powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback